chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had soreness in the left side that radiated to the next and shoulder. To the other side of my right arm and right shoulder. I felt symptoms of possible flu. Fatigue was intense, the chills, the fever. And it lasted about 3 weeks. Previous injections did not give me that reaction. Doctor put me on ibuprofen 6mg, cyclobenzaprine 5mg for 10 days, methylprednisolone 4mg for 6 days. I from time to time still get pain randomly on my thumbs, however my doctor does not believe that is a reaction to the vaccine.
Several episodes of screaming, sweating, followed by rigidly extending arms then being drenched, cold and clammy.  Episodes lasted from 1-2 minutes, longest being 10 minutes.
No additional AE or PQC reported.; administered dose of improperly stored PROQUAD; This spontaneous report was received from an office manager and refers to a 5-year-old male patient. His concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported.  On 14-JUN-2022, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) subcutaneous injection, 1 dose, lot #U017140, expiration date: 28-NOV-2022 (exact dose, vaccination schedule, and route of administration were not provided), administered in right thigh for prophylaxis (Product storage error). It was reported the temperature in the freezer was higher than the recommended temperature for a total of 32 minutes. The reporter stated the freezer corrected itself to the proper range, the Company was contacted. No additional adverse event was reported.  This is one of several reports received from the same reporter.
Pt devel fever of 103.8 R p/DTP/OPV/HIB; pt given APAP temp cont up to 104.1 R; taken to ER given sponge bath, exp 2 episodes of shaking; seen in clinic 2DEC91 urine culture showed UTI;
A couple days after the vaccine I noticed a huge bump possibly a lymph node had appeared on the top of my collar bone and a little behind it about the size of a large to medium marble size. I had an appointment already scheduled with my Dr so I advised her upon that visit of the knot and was advised it could possibly be the immune system beefing up it antibioties and to monitor and if it didn't disappear within a little while to reach back out.  To date its still there but getting smaller by the day
no adverse effect; patient was administered a dose of improper stored ZOSTAVAX; This spontaneous report was received from a registered nurse concerning to a 60-year-old patient of unknown gender. No information was provided regarding the patients' medical history, concurrent conditions or concomitant medications.  On 20-SEP-2019, the patient was vaccinated with an improperly stored dose of Zoster Vaccine Live (ZOSTAVAX) lot number S000617 with expiration date on 06-APR-2020 (dosage schedule, route and anatomical location were not reported) for prophylaxis.  Administered doses of vaccine experienced temperature excursion from 15 to 46 degrees Fahrenheit (F) (45 F) for 720 hours. There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported.
2 MO IMMUNIZATIONS GIVEN ON 6/1/06 SLEEPING ALOT, DECREASED APPETITE, 1 8OZ BOTTLE THE WHOE DAY, FEVER 104 DEGREES RECTAL. PT SENT TO EMERGENCY ROOM SEEING AFTER 2PM HERE AT THE OFFICE. LABS AND XRAYS DONE. TYLENOL BROUGHT TEMP DOWN. PATIENT SENT HOME AWAITING LABS. NO FURTHER PROBLEMS SINCE.
Immediately felt sensation of medication moving throughout my body.  Full body flush, racing heart, Chills and nausea. Loss of balance upon walking. Slept for 11 hours following vaccination.  Pain in injection site and painful lump appeared next to it. Headaches, body aches constantly, as well as constipation. It?s been 11 days since the shot and I still have a headache a small lump. The lump is slowly receding and no longer painful.
brain fog; fever; chills; she's hot but not as often/she was feeling warm; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Nov2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 58 years for covid-19 immunisation. The patient's relevant medical history included: "Headaches" (ongoing); "Relapsing Remitting Multiple sclerosis" (ongoing); "Migraines" (ongoing); "Bladder issues" (ongoing); "heart palpitations" (ongoing); "Muscle spasms" (ongoing). Concomitant medication(s) included: METOPROLOL; OXYBUTYNIN; BACLOFEN; IMITREX. Vaccination history included: Bnt162b2 (DOSE: 1), for COVID-19 Immunization; Bnt162b2 (DOSE: 2), for COVID-19 Immunization; Bnt162b2 (DOSE: 3), for COVID-19 Immunization.  The following information was reported: FEELING ABNORMAL (non-serious) with onset 28Nov2022, outcome "recovered", described as "brain fog"; CHILLS (non-serious) with onset 28Nov2022, outcome "recovered"; PYREXIA (non-serious) with onset 28Nov2022, outcome "recovered", described as "fever"; FEELING HOT (non-serious) with onset 28Nov2022, outcome "recovered", described as "she's hot but not as often/she was feeling warm ".  Additional information: The patient stated there was fevers, chills, and brain fog from the vaccine. The patient stated from time to time she feels like she's hot but not as often, and it gradually tapered off. The patient stated she was feeling warm today and in the last couple days it has tapered off quite a bit.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Inflamed heart and chest wall pain. Went to dr. when breathing and drinking became painful, ekg and chest x-ray were normal. given steroids to reduce inflammation and sent home
-One day later patient had swelling, noticed warmth and redness - Two days later pt had swelling that caused skin sagging, still red and warm
PATIENT BECAME SWEATY, FELT LIKE HE WAS GOING TO PASS OUT.  I CHECKED BP AND PULSE AND BOTH WERE REALLY LOW (AROUND 59/39 AND 30).  I CHECKED IT AGAIN A FEW MINUTES LATER.  IT HADN'T CHANGED AND PATIENT WAS NOT FEELING BETTER.  I CALLED 911.  BY THE TIME THE EMTS ARRIVED, BLOOD PRESSURE WAS CLIMBING AGAIN (112/57 AT 12:26PM AND PULSE 52 BPM).  THEY ASSESSED HIM AND LET HIM GO.
I developed what is being called "Covid Vaccine Arm" a little more than a week after receiving the first dose of the Moderna vaccine in my right arm.  The "rash" spread over my arm from the injection site almost to my elbow.  It was somewhat red, raised, and hot and extremely itchy. It gradually faded and resolved after a week.  I received my 2nd dose of the Moderna vaccine on February 26, 2021. This time--on the advice of my doctor--I got the injection in my left arm.  I started developing a rash again, but this time the day after (2/27/21).  While it does not itch as much as what I experienced previously, my arm has been far more sore and the area of redness (which is raised) is larger than the first time.  I am primarily reporting the first incident, but want to include that it happened again, but more quickly.
Developement of a shingles outbreak. Treated with a 10 day course of Valcyclovir and Lidocaine %5 cream topically. Lesions on trunk, right side, front to back. Lesions dried by August 8 but lingering significant nerve pain to date.
submandible and submaxillary lymph node swelling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Nov2022 as dose 4 (booster), single (Lot number: GJ6665), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Macular degeneration" (unspecified if ongoing), notes: Macular degeneration She takes PreserVision but is not prescription. She has dry macular degeneration; "high blood pressure" (unspecified if ongoing). Concomitant medication(s) included: ATENOLOL taken for hypertension; PRAVASTATIN. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: EM9810; Route of Administration: Intramuscular), administration date: 12Feb2021, when the patient was 76-year-old, for Covid-19 immunization, reaction(s): "She never had any issues with any before this one"; BNT162b2 (DOSE 2, SINGLE; Lot number: EN6208; Route of Administration: Intramuscular), administration date: 12Mar2021, when the patient was 76-year-old, for Covid-19 immunization, reaction(s): "She never had any issues with any before this one"; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot number: 30155BA; Route of Administration: Intramuscular), administration date: 07Oct2021, when the patient was 77-year-old, for Covid-19 immunization, reaction(s): "She never had any issues with any before this one". The following information was reported: LYMPHADENOPATHY (non-serious) with onset 11Nov2022, outcome "recovering", described as "submandible and submaxillary lymph node swelling".  Additional information: The patient received Pfizer covid 19 booster for the fall shot on 03Nov2022. Caller stated it was her 2nd booster. Caller reported her lymph nodes started swelling at midnight on 04Nov2022. Caller stated the sub mandible and sub maxillary lymph nodes were involved. Caller stated the lymph nodes are still slightly swollen. Caller stated her face is not swollen. Caller asked will the lymph nodes recede. This had to be after midnight because she woke up. She is still slightly swollen but has improved slightly and has not gotten worse. The patient took booster dose because everyone says she needs this. The patient knows Pfizer cannot suggest how many days to wait and her lymph nodes are slightly smaller and have no pain unless poking around. The patient asks Pfizer cannot tell her how many days to wait and understands Pfizer cannot give her any information in that direction. The patient did not receive other vaccines within four weeks prior to COVID vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Anatomical location for dose 4 was left upper arm. The patient clarifies her swelling started on 11Nov2022. 4th dose Pfizer COVID-19 Vaccine: 10Nov2022 booster on 10th. The patient relevant medical history macular degeneration she takes preservision but is not prescription. The patient has dry macular degeneration.
Bell's palsy; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration from an unspecified date to an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced bell's palsy on an unspecified date with outcome of unknown. It was reported that the patient had a Bell's palsy a week afterwards and he/she ended up in hospital for a couple of days (unspecified). The patient asked if he/she should take the second dosage because today was the day that she was supposed to get the second one.  Information on lot number/batch number has been requested.
One week later redness/rash/ swollen pone,  hot to the touch, itching  on spot of injection. Upper left arm.  Noticed Sunday morning, 2/22/2021 about 10 AM.  Continued on Monday 2/11/2021.  Benadryl cream used on spot and 1 Benadryl  taken.
This was the second vaccination. Received it about 11:00 am on February 24th and started noticing symptoms about 9:00 am on February 25th. Symptoms were mild: a little sluggishness. No fever. The symptoms were gone after 12 hours.
By error administered a dose from an Expired vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (By error administered a dose from an Expired vial) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021 at 10:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Oct-2021 at 10:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (By error administered a dose from an Expired vial). On 28-Oct-2021 at 10:00 AM, EXPIRED PRODUCT ADMINISTERED (By error administered a dose from an Expired vial) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medication was provided.  Client came to receive their Moderna booster and was by error administered a dose from an expired vial Lot number: 038C21A. Client did not have any adverse reaction. They had notified the client and asked them to return to receive a re-dosing of their Moderna booster with an unexpired vial with Lot number: 037C21A as per their supervision instructions. All questions and concerns were discussed with the client.
Next day after receiving a flu shot I developed symptoms of scratchy throat, excessive mucus discharge and chills. As of today, 5 days after vaccination, symptoms persist, but vary in intensity. Chills are no longer present.
Rt arm was red & warm to touch that pm; pt was tired & had occ. nausea for 3 days.2 wks later,the swelling began & cont.There is a lump at injection site;length approx 2".Arm cont. to be swollen, red,& hot.
Pt recvd HIB-TITER (previous day DTP/OPV given); 24 hrs later, pt became irritable & fussy, t102; Following day exp neck stiffness, bulging fontanelle; Pt presently doing fine;
Patient is a 28 year old male who developed left side facial weakness and numbness a day after his second COVID-19 vaccination. His physical exam was notable for left sided forehead and mouth weakness, with loss of left side blink although forced eye closure intact on the left side.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 71-year-old female patient received BNT162b2 (BNT162B2), on 26Jan2021 at 10:00 as dose 1, single (Lot number: EL9261), in left arm and on 16Feb2021 at 10:00 as dose 2, single (Lot number: EN6201), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing), notes: other medical history: hypothyroidism. Concomitant medication(s) included: LEVOTHYROXIN. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19. No follow-up attempts are possible. No further information is expected.
no adverse effect were reported; improperly stored administered vacine; This spontaneous report was received from a office manager regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and drug allergies were not provided. On 01-OCT-2019, the patient was vaccinated with a dose of inappropriate stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S009758, expiration date: 27-SEP-2020 (strength, dose number and anatomical location were not reported) for prophylaxis (product storage error). The vaccine underwent temperature excursion of 15 Fahrenheit to 46 Fahrenheit (-9 degree Celsius to 8 degree Celsius) (36 Fahrenheit) with unknown time frame. There was no previous temperature excursion involved. A digital data logger was involved. No adverse effects were reported. No product quality complaints (PQC) were involved.
27FEB91 6PM high fever 104.5 w/Tylenol, vomiting & diarrhea x 2 days; 28FEB91 continued temp 103 w/Tylenol; 29FEB91 seen by MD states no more DTP;
rash on hands, head, face, forehead, and nose; rash hurting the patient's hands; Fingers swelling; Itching; chills; This is a spontaneous report from a contactable consumer or other non hcp.A 73-years-old female patient received second dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine,solution for injection,Batch/Lot Number: EN6198, Expiration Date: 30Jun2021), via an unspecified route of administration, administered in Arm Left on 20Feb2021(age at vaccination 73 years) as DOSE 2, SINGLE for covid-19 immunization.The patients medical history and concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number-EN5318,Expiration Date:31May2021) via an unspecified route of administration on 30Jan2021 as dose 1, single for COVID-19 immunization.Patient thought taking BioNTech COVID 19 vaccine was the right thing to do.It was reported that patient was an at-home care provider (not in the medical field) and was reporting on behalf of the patient under her care.Reporter stated that patient got the second dose of the Pfizer covid vaccine on Saturday 20Feb2021. Sunday 21Feb2021 morning, the patient was fine after she woke up. Sunday evening, the patient had chills, not for very long. On Monday 22Feb2021 the patient developed a rash on her hands, head, face, forehead, and nose but her breathing was okay.The rash was hurting the patient's hands, her fingers were swelling and she was itching. Reporter was asking on behalf of patient what is the patient supposed to do about the rash.patient did not receive any treatment for adverse events.The outcome of event chills was recovered on 21Feb2021,outcome of events rash on hands/head/face/forehead /nose,rash hurting the patients hands,fingers  swelling and itching was not recovered.  No follow-up attempts are possible. No further information is expected.
No adverse effects were reported; a 2 month old patient was inadvertently administered a dose of PNEUMOVAX 23; a 2 month old patient was inadvertently administered a dose of PNEUMOVAX 23; This spontaneous report was received from a registered nurse and refers to a 2-month-old patient of unknown gender. The patient's pertinent medical history, concomitant therapies, drug reactions and allergies were not reported.  On 26-JUL-2019, the patient was inadvertently vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (lot #, expiry date, exact dose, route of administration and anatomical location were not provided) for prophylaxis.
On day 3 it started itching; stiff muscle/3 x 4 inches south of vaccine injection; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff muscle/3 x 4 inches south of vaccine injection) and VACCINATION SITE PRURITUS (On day 3 it started itching) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff muscle/3 x 4 inches south of vaccine injection) and VACCINATION SITE PRURITUS (On day 3 it started itching). At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff muscle/3 x 4 inches south of vaccine injection) had resolved and VACCINATION SITE PRURITUS (On day 3 it started itching) outcome was unknown. Not Provided          No Concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15-JUL-2021: Contain No new information
I95.9 HYPOTENSION 4/12/2023 ATHEROSCLEROSIS OF AORTA I95.9 HYPOTENSION 4/12/2023 BRADYCARDIA
Upon giving the MMR (which was the 2nd vaccine, as I had already given the Boostrix) the patient fainted.  She slumped down and I basically caught her in my arms.   I waited until the patient was conscious and then began to fan her with some papers in the vaccine room.  Her boyfriend was waiting outside and I gestured for him to come inside the room.  Once he came inside the room, I had him continue to fan her and sit directly in front of her so that I could leave the room and get some cold compresses.  I returned within a few seconds and put cold compresses on the back of the patient's neck.  We continued with supportive measures for several minutes and then I offered the patient a water.  She agreed and I again left the room to get water and a more supportive fan ( a clipboard).  I returned with the water and the clipboard and the patient drank the water and I was able to fan the patient better with the clipboard.  After another 5 minutes or so the patient said she felt better and was ok to leave the room and sit outside with her boyfriend.  So we moved them outside the room to some waiting room chairs for her to sit and continue to drink the water and relax.  After about 10 minute she said she felt fine and went home.
On Thursday 4/21/11 at 4:40 pm pt began seizuring. Mother called squad. Seizure lasted 20-25 minutes. Squad gave ATIVAN. No fever at home, in squad or in Emergency Room. No other complaints. Pt was acting normally, eating cracker at 4:30 pm 4/21/11 before seizure.
took the vaccine THEN had Shingles/ suspected vaccination failure; light case of shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received Shingles vaccine and had shingles. The physician assured that it was a light case. The patient was thrilled that he/she did not have heavy case as they were horrible. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.